Donor selection for allogeneic hematopoietic cell transplantation

BACKGROUND: In Germany, each year over 3000 patients with malignant and non-malignant hematologic and systemic diseases are treated by allo - geneic hematopoietic cell transplantation (HCT). Genetic donor-recipient disparities, especially those concerning variable human leukocyte antigens (HLA), med...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fleischhauer, Katharina (VerfasserIn) , Tran, Thuong Hien (VerfasserIn) , Meisel, Roland (VerfasserIn) , Mytilineos, Joannis (VerfasserIn) , Dreger, Peter (VerfasserIn) , Kröger, Nicolaus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 April 2023
In: Deutsches Ärzteblatt
Year: 2023, Jahrgang: 120, Heft: 15, Pages: 261-268, I-II
ISSN:1866-0452
DOI:10.3238/arztebl.m2023.0031
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3238/arztebl.m2023.0031
Verlag, lizenzpflichtig, Volltext: https://www.aerzteblatt.de/int/archive/article/230669
Volltext
Verfasserangaben:Katharina Fleischhauer, Thuong Hien Tran, Roland Meisel, Joannis Mytilineos, Peter Dreger, Nicolaus Kröger

MARC

LEADER 00000caa a2200000 c 4500
001 1858799856
003 DE-627
005 20240722141538.0
007 cr uuu---uuuuu
008 230905s2023 xx |||||o 00| ||eng c
024 7 |a 10.3238/arztebl.m2023.0031  |2 doi 
035 |a (DE-627)1858799856 
035 |a (DE-599)KXP1858799856 
035 |a (OCoLC)1425212413 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fleischhauer, Katharina  |d 1963-  |e VerfasserIn  |0 (DE-588)1246979349  |0 (DE-627)1780384173  |4 aut 
245 1 0 |a Donor selection for allogeneic hematopoietic cell transplantation  |c Katharina Fleischhauer, Thuong Hien Tran, Roland Meisel, Joannis Mytilineos, Peter Dreger, Nicolaus Kröger 
264 1 |c 14 April 2023 
300 |a Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.09.2023 
520 |a BACKGROUND: In Germany, each year over 3000 patients with malignant and non-malignant hematologic and systemic diseases are treated by allo - geneic hematopoietic cell transplantation (HCT). Genetic donor-recipient disparities, especially those concerning variable human leukocyte antigens (HLA), mediate both an immunotherapeutic effect and the risk of damage to healthy tissues ("graft-versus-host disease"). The adoption of evidencebased strategies for donor selection has been crucial for the continuous improvement of survival rates after allogeneic HCT, with over 50% of patients transplanted for standard indications-such as early-stage acute myeloid leukemia-alive at three years post-transplant. METHODS: The PubMed database was selectively searched for literature on immunogenetic and clinical factors relevant to allogeneic HCT, as part of the process of establishing a German consensus statement on HCT donor selection. RESULTS: The most important factor in donor selection is a match for the five major HLA loci (HLA-A, -B, -C, -DR, -DQ), either in genetically HLAidentical siblings or in unrelated but fully HLA-compatible donors from international registries. Additional selection criteria for the latter include com - patibility for the HLA-DP locus, donor age and sex, cytomegalovirus serostatus, and blood group. Related donors identical for only 50% of the HLA genes (haploidentical donors) as well as unrelated donors with a single HLA mismatch are both valid alternatives although they are associated with an up to 10% higher risk of mortality. CONCLUSION: The refinement of donor selection strategies has been instrumental for the continuous improvement of patient survival rates after allogeneic HCT witnessed over the past decades. An interdisciplinary approach to donor selection based on up-to-date scientific evidence is crucial for optimizing patient outcomes. 
650 4 |a donor selection 
650 4 |a graft vs host disease 
650 4 |a hematopoietic stem cell transplantation 
650 4 |a HLA antigens 
650 4 |a humans 
650 4 |a leukemia, myeloid, acute 
650 4 |a retrospective studies 
650 4 |a unrelated donors 
700 1 |a Tran, Thuong Hien  |d 1965-  |e VerfasserIn  |0 (DE-588)113498128  |0 (DE-627)691186030  |0 (DE-576)171410513  |4 aut 
700 1 |a Meisel, Roland  |d 1969-  |e VerfasserIn  |0 (DE-588)121432645  |0 (DE-627)705453308  |0 (DE-576)292707401  |4 aut 
700 1 |a Mytilineos, Joannis  |e VerfasserIn  |0 (DE-588)1076347819  |0 (DE-627)834742268  |0 (DE-576)166586900  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Kröger, Nicolaus  |d 1959-  |e VerfasserIn  |0 (DE-588)112156533  |0 (DE-627)477107354  |0 (DE-576)167115103  |4 aut 
773 0 8 |i Enthalten in  |t Deutsches Ärzteblatt  |b International : a weekly online journal of clinical medicine and public health  |d Köln : Dt. Ärzte-Verl., 2006  |g 120(2023), 15, Seite 261-268, I-II  |h Online-Ressource  |w (DE-627)557878810  |w (DE-600)2406159-1  |w (DE-576)281368007  |x 1866-0452  |7 nnas  |a Donor selection for allogeneic hematopoietic cell transplantation 
773 1 8 |g volume:120  |g year:2023  |g number:15  |g pages:261-268, I-II  |g extent:10  |a Donor selection for allogeneic hematopoietic cell transplantation 
856 4 0 |u https://doi.org/10.3238/arztebl.m2023.0031  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.aerzteblatt.de/int/archive/article/230669  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230905 
993 |a Article 
994 |a 2023 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1076347819  |a Mytilineos, Joannis  |m 1076347819:Mytilineos, Joannis  |p 4 
998 |g 113498128  |a Tran, Thuong Hien  |m 113498128:Tran, Thuong Hien  |d 910000  |d 911600  |e 910000PT113498128  |e 911600PT113498128  |k 0/910000/  |k 1/910000/911600/  |p 2 
999 |a KXP-PPN1858799856  |e 4372889275 
BIB |a Y 
SER |a newspaper 
JSO |a {"title":[{"title":"Donor selection for allogeneic hematopoietic cell transplantation","title_sort":"Donor selection for allogeneic hematopoietic cell transplantation"}],"person":[{"display":"Fleischhauer, Katharina","family":"Fleischhauer","given":"Katharina","role":"aut"},{"role":"aut","display":"Tran, Thuong Hien","family":"Tran","given":"Thuong Hien"},{"given":"Roland","family":"Meisel","display":"Meisel, Roland","role":"aut"},{"role":"aut","given":"Joannis","family":"Mytilineos","display":"Mytilineos, Joannis"},{"family":"Dreger","display":"Dreger, Peter","given":"Peter","role":"aut"},{"display":"Kröger, Nicolaus","family":"Kröger","given":"Nicolaus","role":"aut"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"language":["eng","ger"],"id":{"eki":["557878810"],"issn":["1866-0452"],"zdb":["2406159-1"]},"type":{"media":"Online-Ressource","bibl":"newspaper"},"origin":[{"publisherPlace":"Köln","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"Dt. Ärzte-Verl.","edition":"International : a weekly online journal of clinical medicine and public health"}],"part":{"pages":"261-268, I-II","text":"120(2023), 15, Seite 261-268, I-II","volume":"120","issue":"15","year":"2023","extent":"10"},"titleAlt":[{"title":"Deutsches Ärzte-Blatt"}],"title":[{"title_sort":"Deutsches Ärzteblatt","title":"Deutsches Ärzteblatt"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Donor selection for allogeneic hematopoietic cell transplantationDeutsches Ärzteblatt","pubHistory":["103.2006 -"],"recId":"557878810","note":["Gesehen am 15.8.2025"]}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"14 April 2023"}],"type":{"media":"Online-Ressource","bibl":"article-newspaper"},"id":{"eki":["1858799856"],"doi":["10.3238/arztebl.m2023.0031"]},"language":["eng"],"name":{"displayForm":["Katharina Fleischhauer, Thuong Hien Tran, Roland Meisel, Joannis Mytilineos, Peter Dreger, Nicolaus Kröger"]},"note":["Gesehen am 05.09.2023"],"recId":"1858799856"} 
SRT |a FLEISCHHAUDONORSELEC1420